Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GALSULFASE vs GEMCITABINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

GALSULFASE vs GEMCITABINE: Safety Overview

Metric GALSULFASE GEMCITABINE
Total FAERS Reports 2,809 31,328
Deaths Reported 238 5,142
Death Rate 8.5% 16.4%
Hospitalizations 1,007 12,268
Average Patient Age 16.3 yrs 61.2 yrs
% Female Patients 53.7% 48.4%
FDA Approval Date N/A Apr 11, 2016
Manufacturer BioMarin Pharmaceutical Inc. Hikma Pharmaceuticals USA Inc.
Route INTRAVENOUS INTRAVENOUS
Marketing Status Prescription Discontinued